Page 79 - Read Online

Page 124 Ghaseminejad et al. J Transl Genet Genom 2022;6:111-25 https://dx.doi.org/10.20517/jtgg.2021.49

Authors’ contributions
Farhad Ghaseminejad Performed the experiments, wrote the manuscript, and contributed to experimental
design: Ghaseminejad F
Developed protocols, assisted with experiments, and contributed to experimental design: Tam BM
Assisted with experiments, developed the Rho.LΔ11Δ1 line, and performed the Rho.L knockout analysis:
Chiu CN
Developed protocols, and initiated the development of the Rho.LΔ11Δ1 line: Feehan JM
Conceived of the study, obtained funding, and edited the manuscript: Moritz OL

Availability of data and materials
Not applicable.

Financial support and sponsorship
This study was funded by the Canadian Institutes of Health Research (PJT-155937 and PJT-156072) and the
National Science and Engineering Research Council (RGPIN-2020-05193). Ghaseminejad F was the
recipient of a scholarship from the Canadian Institutes of Health Research (Canada Graduate Scholarships -
Master’s Program).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
These studies were approved by the UBC animal care committee, certificates A18-0259 and A18-0257. Our
experiments conformed to the ARVO statement for the use of animals in ophthalmic and vision research.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis 2006;1:40. DOI PubMed PMC
2. Retinitis pigmentosa. Fighting Blindness Canada (FBC). Available from: https://www.fightingblindness.ca/eye-diseases-
pathways/retinitis-pigmentosa/ [Last accessed on 12 Jan 2022].
3. Verbakel SK, van Huet RAC, Boon CJF, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res 2018;66:157-86. DOI
PubMed
4. Daiger SP, Sullivan LS, Bowne SJ. Genes and mutations causing retinitis pigmentosa. Clin Genet 2013;84:132-41. DOI PubMed
PMC
5. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet 2006;368:1795-809. DOI PubMed
6. Athanasiou D, Aguila M, Bellingham J, et al. The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential
strategies for therapy. Prog Retin Eye Res 2018;62:1-23. DOI PubMed PMC
7. Rosenfeld PJ, Cowley GS, McGee TL, Sandberg MA, Berson EL, Dryja TP. A null mutation in the rhodopsin gene causes rod
photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet 1992;1:209-13. DOI PubMed
8. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014;157:1262-78. DOI
PubMed PMC
9. Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in
adaptive bacterial immunity. Science 2012;337:816-21. DOI PubMed PMC
10. Wang D, Zhang C, Wang B, et al. Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning. Nat
Commun 2019;10:4284. DOI PubMed PMC
11. Zaboikin M, Zaboikina T, Freter C, Srinivasakumar N. Non-homologous end joining and homology directed DNA repair frequency of
double-stranded breaks introduced by genome editing reagents. PLoS One 2017;12:e0169931. DOI PubMed PMC
12. Feehan JM, Chiu CN, Stanar P, Tam BM, Ahmed SN, Moritz OL. Modeling dominant and recessive forms of retinitis pigmentosa by
editing three rhodopsin-encoding genes in Xenopus laevis using Crispr/Cas9. Sci Rep 2017;7:6920. DOI PubMed PMC